Clinical Trial Update: Neoadjuvant Endocrine Therapy in Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial update evaluating neoadjuvant endocrine therapy in highly endocrine-responsive operable breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Guangdong Provincial People's Hospital | Conditions: Highly Endocrine Responsive Operable Breast Cancer | Phase 2 | Status: COMPLETED